DPUKY 8.34   +0.330 +4.10% Updated: 09-24-2017 $DPUKY

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
25
DPUKY 8.34   +0.330 +4.10% Updated: 09-24-2017 $DPUKY
Last Trade: 9/22/2017 3:52:00 PM

Last 8.34   +0.330 +4.10%
Open 8.09
Previous Close 8.01
Day High / Low 8.34 / 8.09
Year High / Low - / -
Volume 5,642
Projected Volume 5642 (66%)
# of Trades / Projected 6 / 6
Dividend / Yield - / -
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle BULLISH
Volatility Today HIGH
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 104%
From 80 Day High 95%
From 150 Day High 76%
From 40 Day Low 119%
From 80 Day Low 119%
From 150 Day Low 119%
Pivot Analysis
Price Pivot $ 8.26
Day Resistance 1 $ 8.42
Day Support 1 $ 8.17
Day Resistance 2 $ 8.51
Day Support 2 $ 8.01
Consolidations
Short Term NO
Medium Term NO
Long Term YES
Volume Indicators
20 Day Avg Vol 8,537
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 17,953
Today / 150 Day Avg Vol BELOW
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bearish
Stochastics neutral
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bullish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today HIGH
Volatility Index Yesterday HIGH
10 Day Volatility INCREASING
20 Day Volatility INCREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Pharma Marketing's Systemic Crisis Unveiled by Doceree

Updated Category News Views 35

Complex Inefficiencies Emerge in Pharma Marketing There's a jaw-dropping truth that Doceree just spotlighted about the pharmaceutical marketing game: the industry's been working with blinders on. The findings from their latest survey, "The Broken Command Center," expose a rotting tree in the field of pharma marketing—fragmented systems that limp along like a centipede...

Continue Reading
Boulevard Capital Shines as LendTech Finalist in 2024 Awards

Updated Category News Views 54

Boulevard Capital Recognized in the FinTech Sector Boulevard, the provider of a client experience platform tailored for appointment-based self-care businesses, has recently achieved recognition as a finalist for LendTech of the Year at the prestigious 2024 US FinTech Awards. These awards honor the leading innovators and significant achievements within the rapidly growing...

Continue Reading
Mitchell Partners with PAVE to Enhance Vehicle Inspection Technology

Updated Category News Views 103

Mitchell Enhances Intelligent Solutions with AI Vehicle Inspections Mitchell, a company under Enlyte known for its innovative technology in the property and casualty claims industry, is thrilled to announce a new collaboration with PAVE. This partnership is set to transform and automate vehicle inspections by integrating Mitchell's advanced cloud-based appraisal solutions...

Continue Reading
Oracle Empowers Defense with Tailored Tech

Updated Category News Views 7

Oracle's Strategic Boost for Defense Innovation Today's defense landscape isn't for the faint of heart, and Oracle's stepping up to bat with its Defense Ecosystem initiative. When you're talking about security and military tech, timelines drag longer than they'd like. But boy, Oracle's cutting to the chase—melding tech innovation with real-world application before you...

Continue Reading
Methode Electronics Prepares for Upcoming Quarterly Earnings Call

Updated Category News Views 130

Upcoming Earnings Call for Methode Electronics, Inc. In the ever-evolving world of technology, Methode Electronics, Inc. (NYSE: MEI) stands out as a key player, delivering innovative solutions for user interfaces, lighting systems, and power distribution applications. The company has recently announced its plan to release financial results for the first quarter of fiscal...

Continue Reading